• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Improved coagulation screening by an activated recalcification test.
J Clin Pathol. 1967 May;20(3):244-8. doi: 10.1136/jcp.20.3.244.
2
Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties.一种新的血浆凝血活酶因子的证据。I. 病例报告、凝血研究及物理化学性质。
Blood. 1965 Nov;26(5):521-32.
3
The activated plasma recalcification time. A Measurement encompassing the activated partial thromboplastin time and platelet function, with improved detection of bleeders.
Am J Clin Pathol. 1975 Jul;64(1):80-6. doi: 10.1093/ajcp/64.1.80.
4
The anticoagulant activity of lysosomal cationic proteins from polymorphonuclear leukocytes.多形核白细胞溶酶体阳离子蛋白的抗凝活性。
J Clin Invest. 1967 Apr;46(4):580-9. doi: 10.1172/JCI105559.
5
[Interpretation of screening tests of hemostasis].[止血筛查试验的解读]
Praxis (Bern 1994). 2003 Jan 15;92(3):57-64. doi: 10.1024/0369-8394.92.3.57.
6
Routine tests as measures of the total intrinsic blood clotting potential. A comparison of whole blood clotting time (WBCT), recalcification time of citrated plasma (RTST), partial thromboplastin time (PTT), and activated partial thromboplastin time (APTT).作为总内源性凝血潜力指标的常规检测。全血凝固时间（WBCT）、枸橼酸盐血浆再钙化时间（RTST）、部分凝血活酶时间（PTT）和活化部分凝血活酶时间（APTT）的比较。
Scand J Haematol. 1971;8(5):359-68.
7
[The kaolin-activated recalcification test in the screening of coagulation disorders and in the control of anticoagulant therapy].
Quad Sclavo Diagn. 1977 Jun;13(2):167-75.
8
STARCH BLOCK ELECTROPHORESIS OF PLASMA AND SERUM CLOTTING FACTORS. SEPARATION OF ACTIVATED PTC (PTC).血浆和血清凝血因子的淀粉块电泳。活化PTC（PTC）的分离。
Blood. 1965 May;25:724-35.
9
The kaolin partial thromboplastin time as a screening test for coagulation disorders.高岭土部分凝血活酶时间作为凝血障碍的筛查试验。
S Afr Med J. 1968 May 4;42(18):438-44.
10
[BLOOD CLOTTING FACTOR IN HEMOLYSATES].[溶血产物中的血液凝固因子]
Nihon Ketsueki Gakkai Zasshi. 1963 Dec;26:779-87.

引用本文的文献

1
Antiplatelet, Anticoagulant, and Fibrinolytic Activity of Orchids: A Review.兰花的抗血小板、抗凝和纤溶活性：综述
Molecules. 2024 Dec 3;29(23):5706. doi: 10.3390/molecules29235706.
2
A tick saliva serpin, IxsS17 inhibits host innate immune system proteases and enhances host colonization by Lyme disease agent.一种蜱唾液丝氨酸蛋白酶抑制剂，IxsS17 抑制宿主固有免疫系统蛋白酶，并增强莱姆病病原体对宿主的定殖。
PLoS Pathog. 2024 Feb 23;20(2):e1012032. doi: 10.1371/journal.ppat.1012032. eCollection 2024 Feb.
3
Bacterial-Nanocellulose-Based Biointerfaces and Biomimetic Constructs for Blood-Contacting Medical Applications.用于血液接触医学应用的基于细菌纳米纤维素的生物界面和仿生构建体。
ACS Mater Au. 2023 Jun 27;3(5):418-441. doi: 10.1021/acsmaterialsau.3c00021. eCollection 2023 Sep 13.
4
Simultaneous assessment of blood coagulation and hematocrit levels in dielectric blood coagulometry.在介电血液凝固法中同时评估血液凝固和血细胞比容水平。
Biorheology. 2017;54(1):25-35. doi: 10.3233/BIR-16118.
5
Effect of lactation suppressants on the coagulation mechanism.泌乳抑制剂对凝血机制的影响。
Can Med Assoc J. 1974 Apr 20;110(8):905-9.
6
A modified whole blood partial thromboplastin test for the assessment of heparinization.一种用于评估肝素化的改良全血部分凝血活酶时间试验。
Can Med Assoc J. 1973 Jun 23;108(12):1505-8.
7
Chlormadinone acetate and its effect on the hemostatic mechanism.醋酸氯地孕酮及其对止血机制的影响。
Can Med Assoc J. 1972 Jul 8;107(1):38-41.

本文引用的文献

1
The partial thromboplastin time as a screening test for the detection of latent bleeders.部分凝血活酶时间作为检测潜在出血者的筛查试验。
Am J Med Sci. 1962 Mar;243:279-87. doi: 10.1097/00000441-196203000-00002.
2
RAPID SCREENING METHODS FOR BLEEDING DISORDERS. A THREE YEAR SURVEY.出血性疾病的快速筛查方法。一项为期三年的调查。
Thromb Diath Haemorrh. 1964 Jul 31;11:506-12.
3
A RAPID BEDSIDE TEST FOR FIBRINOLYSIS AND HYPOFIBRINOGENAEMIA.
J Ir Med Assoc. 1963 Dec;53:194.
4
A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma.一期因子VIII（抗血友病球蛋白）测定及其在静脉血浆和毛细血管血浆中的应用。
Thromb Diath Haemorrh. 1962 May 15;7:215-28.
5
A study on the pathogenesis of thrombopathia using the platelet osmotic-resistance test.
Br J Haematol. 1959 Jul;5:302-6. doi: 10.1111/j.1365-2141.1959.tb04038.x.
6
The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.高岭土部分凝血活酶时间。用于筛查第一阶段血浆凝血因子缺乏症的简单检测。
Am J Clin Pathol. 1961 Sep;36:212-9. doi: 10.1093/ajcp/36.3.212.
7
Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by 6-aminocaproic acid.6-氨基己酸对纤溶酶、胰蛋白酶及链激酶激活的纤溶系统的抑制作用。
Arch Biochem Biophys. 1959 May;82(1):153-60. doi: 10.1016/0003-9861(59)90100-6.
8
Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition.哈格曼因子在玻璃引发凝血过程中的作用；玻璃使哈格曼因子解除抑制的证据。
Am J Med. 1958 Aug;25(2):160-8. doi: 10.1016/0002-9343(58)90023-8.
9
Methods for the evaluation of human fibrinolysis; studies with two combined technics.人类纤维蛋白溶解评估方法；两种联合技术的研究
Am J Clin Pathol. 1958 Feb;29(2):104-12. doi: 10.1093/ajcp/29.2.104.
10
Detecting blood coagulation defects in the clinical laboratory.
Am J Med Technol. 1957 Sep-Oct;23(5):277-82.

Improved coagulation screening by an activated recalcification test.

作者信息

Hunter D T, Allensworth J L

出版信息

J Clin Pathol. 1967 May;20(3):244-8. doi: 10.1136/jcp.20.3.244.

DOI:10.1136/jcp.20.3.244
PMID:5602556
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC473477/
Abstract

The conventional plasma recalcification test is improved by incubation of test plasma with Celite suspended in distilled water. This effectively activates factor XII and releases platelet factor 3, thereby markedly shortening the clotting time. The modified plasma recalcification test has several advantages that contribute to its usefulness as a general screening test for coagulation abnormalities. It is more precise and reproducible than any comparable test that assays a similar spectrum of coagulation factors.

摘要